Loading...
132 Middle East and Africa Chronic Disorder Drugs Reports
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: Egypt, Iran, Oman, Saudi Arabia, South Africa
Major Players: Bristol Myers Squibb, Teva, Sanofi Aventis, Merck and Co., Glenmark Pharmaceuticals
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Boehringer Ingelheim, Astrazeneca, Eli Lilly, Sanofi, Novo Nordisk
Country Covered: Egypt
Study Period: 2019 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Country Covered: Saudi Arabia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Merck and Co., Novo Nordisk A/S, Sanofi Aventis
Country Covered: South Africa
Study Period: 2018 - 2029
Major Players: AstraZeneca, Merck, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca PLC, Bayer AG, F. Hoffmann La-Roche Ltd, Teva Pharmaceutical Industries Ltd, Seagen Inc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, SymBio Pharmaceuticals Limited, Genmab AS
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson (Janssen Pharmaceuticals Inc.), Novartis AG, Bristol Myers Squibb Company, Merck & Co. Inc, F. Hoffmann-La Roche Ltd
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol Myers Squibb, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, GlaxoSmithKline (GSK) PLC
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Otsuka holdings co., ltd., Bristol Myers Squibb
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., AstraZeneca PLC, Hoffmann-La Roche AG, Eli Lilly and Company , GSK plc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Abbvie, F. Hoffmann-La Roche Ltd
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bausch Health Companies Inc., Novartis AG, AbbVie Inc., Almirall SA
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company
Region Covered: Middle East and Africa
Study Period: 2020 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Novartis International AG, Sanofi S.A.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Bayer AG, Pfizer Inc., Novartis International AG, Johnson and Johnson
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG, Amgen Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol‑Myers Squibb Company, Eisai Co., Ltd., Exelixis Inc, Merck & Co. Inc., Bayer AG
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Baxter International, Inc., GlaxoSmithKline PLC, Pfizer, Inc., Johnson & Johnson, Novartis AG
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Teva Pharmaceuticals, L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique), Sun Pharmaceutical Industries, Inc., JOHNSON & JOHNSON, Abbvie Inc (Allergan PLC)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis AG, Merck Co & Inc., Fresenius Kabi, Pfizer Inc., Eli Lilly & Co.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd, Celltrion Inc., Merck & Co
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc.,, Novartis AG, Bausch Health Companies Inc. , Johnson & Johnson
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb Company, Merck & Co. Inc., Biogen Inc., Amneal Pharmaceuticals, Inc., Seagen Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: GlaxoSmithKline Plc, Merck & Co Inc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Novartis AG
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer AG, F. Hoffmann-La Roche Ltd, Eisai Inc., Novartis AG, Merck & Co. Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Elekta AB, Karyopharm Therapeutics, Eisai Co., Ltd., GSK plc, Siemens Healthineers (Varian Medical Systems, Inc.)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline, Eli Lilly and Company, Bausch Health
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Axogen Corporation, Medtronic, Boston Scientific Corporation, Integra LifeSciences Corporation
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Medtronic PLC, Astellas Pharma, Inc., Macleods Pharmaceuticals Ltd, Pfizer, Inc, AbbVie Ltd.
Filter Reports
By Countries
